What is Tidepool?
Tidepool operates as a specialized nonprofit entity focused on the intersection of medical device data and patient care. Its core value proposition centers on the Tidepool Loop, a pioneering automated insulin dosing application designed to bridge the gap between disparate medical hardware and actionable health insights. By facilitating seamless data integration, the organization empowers healthcare professionals to deliver more precise, data-driven interventions. This platform serves as a vital conduit for telemedicine, effectively modernizing the standard of care for individuals managing diabetes through enhanced connectivity and user-centric design.
How much funding has Tidepool raised?
Tidepool has raised a total of $1.4M across 2 funding rounds:
Debt
$350K
Debt
$1M
Debt (2020): $350K with participation from PPP
Debt (2021): $1M led by PPP
Key Investors in Tidepool
PPP
Public-Private Partnership
What's next for Tidepool?
With this major enterprise-level funding, Tidepool is positioned to accelerate the deployment of its interoperable ecosystem. The strategic roadmap likely involves expanding the compatibility of its software suite across a broader array of medical devices, thereby solidifying its market position as a foundational layer in diabetes technology. As the organization scales, the focus will remain on enhancing the robustness of its data platform to support larger telemedicine networks and clinical research initiatives, ensuring that patients and providers maintain a unified, real-time view of health metrics. This capital injection provides the necessary runway to navigate regulatory landscapes and drive widespread adoption of automated insulin delivery systems.
See full Tidepool company page
